Igor Proscurshim

Igor Proscurshim is a medical professional with extensive experience in drug development and clinical research, particularly in oncology.1 He is a surgeon by training who transitioned into the pharmaceutical industry to focus on developing life-saving medicines.1

Career Highlights

• Current Position: Vice President Clinical Development at DynamiCure Biotechnology (since September 2022)1
• Previous Roles:
  • Vice President - Head of Clinical Development at Ichnos Sciences
  • Senior Medical Director at Takeda Oncology
  • Director of Business Development at Agenus
  • Chief Scientific Officer at Recepta Biopharma

Background and Expertise

• Surgical background with 10+ years of clinical surgical research, focusing on colorectal cancer1
• Extensive experience in drug development, including:
  • Transitioning drug candidates into pre-clinical and IND-enabling programs
  • Elaborating clinical development strategies
  • Managing candidate drug portfolios
  • In-licensing and out-licensing of intellectual property1

Notable Achievements

• Led the out-licensing of IP to Mersana while at Recepta Biopharma1
• Responsible for structuring medical monitoring across all therapeutic areas at Takeda Oncology1
• Introduced technology to improve medical monitoring and data review at Takeda1
• Currently leads a team developing promising oncology programs at DynamiCure Biotechnology1

Igor Proscurshim's diverse experience in both clinical practice and pharmaceutical development has positioned him as a valuable professional in the field of oncology drug development.